Laughter Yoga- Integrated Virtual Reality Nature Exploration in Early Stage of Chemotherapy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAtaturk University

About this trial

After obtaining informed consent, pre-test applications will be performed on participants in the experimental and control groups following randomization, and information regarding treatment plans will be recorded. Patients in the experimental group will receive laughter yoga practice integrated with virtual reality videos during chemotherapy infusion. The practice is planned to be once a week for four weeks. High-resolution, adjustable virtual reality glasses with head and hand tracking features will be used for the virtual reality application. The videos will consist of relaxing content such as nature walks, beach and sea views, and will be prepared in three-dimensional, 360-degree viewing angles integrated with laughter yoga exercises. Personalized video content will be created according to the participants' preferences, and the viewing time will be limited to 10 minutes for each application. After the completion of the fourth course, data collection tools will be re-administered for post-testing purposes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • laughter yoga-integrated virtual reality

    Behavioral

    A digital-based behavioral approach for symptom control

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: controlNo intervention 0 interventions
Group B: intervientionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Pittsburgh Sleep Quality Index

This self-report scale, used to assess sleep quality and sleep-related problems, consists of seven components. The scale was first developed by Buysse et al. in 1989, and studies have shown that it has sufficient internal consistency (Cronbach's alpha=0.80), test-retest reliability, and construct validity. The Turkish validity and reliability study of the scale was carried out by Ağargün et al., and it was shown that it can be used in the Turkish population.

Time frame
4 week
2

State-Trait Anxiety Inventory (STAI)

Developed by Spielberger et al. and adapted into Turkish by Öner and Le Compte, this inventory assesses anxiety levels. It includes two subscales, each consisting of 20 items, measuring the individual's immediate anxiety level and general anxiety tendency separately. The scale is evaluated on a four-point Likert scale, with scores ranging from 20 to 80, indicating a higher level of anxiety.

Time frame
4 week

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: